Home > Products > EGFR & MET
> Recombinant Anti-EGFR x Anti-MET sdAb Bispecific Antibody (IgG-sdAb)
Recombinant Anti-EGFR x Anti-MET sdAb Bispecific Antibody (IgG-sdAb) (CAT#: IGVHH-044)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (IgG-sdAb) is designed to be expressed as a LC and an extended HC with a sdAb linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy. As required, the sdAb can also be fused to the C terminus of the LC.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-MET sdAb Bispecific Antibody (IgG-sdAb) (IGVHH-044). Click the button below to contact us or submit your feedback about this product.